CN115776898A - 双特异性抗体及其应用 - Google Patents
双特异性抗体及其应用 Download PDFInfo
- Publication number
- CN115776898A CN115776898A CN202180047898.6A CN202180047898A CN115776898A CN 115776898 A CN115776898 A CN 115776898A CN 202180047898 A CN202180047898 A CN 202180047898A CN 115776898 A CN115776898 A CN 115776898A
- Authority
- CN
- China
- Prior art keywords
- seq
- sequence
- amino acid
- sequence shown
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Peptides Or Proteins (AREA)
Abstract
提供了双特异性抗体及其应用,双特异性抗体或抗原结合片段可以结合两个抗原,或同一抗原的两个个表位。抗体或抗原结合片段可以用于治疗各种疾病,比如炎性疾病、自体免疫性疾病、癌症或脊髓损伤,也可以用于相关疾病的诊断和预后。
Description
PCT国内申请,说明书已公开。
Claims (22)
- PCT国内申请,权利要求书已公开。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010643073 | 2020-07-07 | ||
CN2020106430738 | 2020-07-07 | ||
PCT/CN2021/104810 WO2022007807A1 (zh) | 2020-07-07 | 2021-07-06 | 双特异性抗体及其应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115776898A true CN115776898A (zh) | 2023-03-10 |
Family
ID=79552784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202180047898.6A Pending CN115776898A (zh) | 2020-07-07 | 2021-07-06 | 双特异性抗体及其应用 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN115776898A (zh) |
WO (1) | WO2022007807A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024193516A1 (zh) * | 2023-03-17 | 2024-09-26 | 百奥泰生物制药股份有限公司 | 抗ox40抗体在治疗炎症或免疫性疾病中的应用 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023198015A1 (zh) * | 2022-04-11 | 2023-10-19 | 江苏恒瑞医药股份有限公司 | 特异性结合psma和cd28的抗原结合分子及其医药用途 |
CN117618555A (zh) * | 2022-08-31 | 2024-03-01 | 百奥泰生物制药股份有限公司 | 抗tigit抗体和抗ctla-4抗体联合用于治疗肿瘤中的应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101870555B1 (ko) * | 2011-08-23 | 2018-06-22 | 로슈 글리카트 아게 | T 세포 활성화 항원 및 종양 항원에 대해 특이적인 이중특이적 항체 및 이의 사용 방법 |
CA2844143C (en) * | 2011-08-23 | 2018-07-31 | Roche Glycart Ag | Fc-free antibodies comprising two fab fragments and methods of use |
MA40510A (fr) * | 2014-08-04 | 2017-06-14 | Hoffmann La Roche | Molécules bispécifiques de liaison à l'antigène activant les lymphocytes t |
BR112017010324A2 (pt) * | 2014-11-20 | 2018-05-15 | F. Hoffmann-La Roche Ag | método para tratar ou retardar a progressão de um câncer em um indivíduo, moléculas, métodos para aumentar a função imune em um indivíduo e para selecionar um paciente para tratamento, kits, composição farmacêutica e usos de uma combinação de uma molécula |
EP3356407B1 (en) * | 2015-10-02 | 2021-11-03 | F. Hoffmann-La Roche AG | Bispecific anti-cd19xcd3 t cell activating antigen binding molecules |
JP2018533930A (ja) * | 2015-10-02 | 2018-11-22 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | 二重特異性t細胞活性化抗原結合分子 |
PL3519437T3 (pl) * | 2016-09-30 | 2022-01-17 | F. Hoffmann-La Roche Ag | Przeciwciała dwuswoiste przeciwko p95HER2 |
CN110352200B (zh) * | 2018-02-06 | 2020-12-11 | 天境生物科技(上海)有限公司 | 抗具有Ig和ITIM结构域的T细胞免疫受体(TIGIT)的抗体及其应用 |
AR118619A1 (es) * | 2019-04-10 | 2021-10-20 | Bio Thera Solutions Ltd | Anticuerpos de unión a pd-1 |
EP4026846A4 (en) * | 2019-09-03 | 2023-09-13 | Bio-Thera Solutions, Ltd. | ANTI-TIGITE IMMUNOSUPPRESSANT AND USE THEREOF |
-
2021
- 2021-07-06 CN CN202180047898.6A patent/CN115776898A/zh active Pending
- 2021-07-06 WO PCT/CN2021/104810 patent/WO2022007807A1/zh active Application Filing
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024193516A1 (zh) * | 2023-03-17 | 2024-09-26 | 百奥泰生物制药股份有限公司 | 抗ox40抗体在治疗炎症或免疫性疾病中的应用 |
Also Published As
Publication number | Publication date |
---|---|
WO2022007807A1 (zh) | 2022-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2010220421B9 (en) | Antibodies against a proliferating inducing ligand (APRIL) | |
US11555077B2 (en) | 4-1BB antibody and preparation method and use thereof | |
AU2019412405B2 (en) | Antibody against human IL-4RA and use thereof | |
WO2021238932A1 (zh) | 多特异性抗体及其应用 | |
WO2022007807A1 (zh) | 双特异性抗体及其应用 | |
US20240092892A1 (en) | Anti-cldn18.2 antibody, and preparation method therefor and use thereof | |
WO2019141268A1 (zh) | 抗4-1bb抗体、其抗原结合片段及其医药用途 | |
KR20200106056A (ko) | 자가면역 질환 및 암을 치료하기 위한 항-cxcl13 항체 | |
WO2024012539A1 (zh) | 抗Nectin-4抗体及其应用 | |
AU2021411652A1 (en) | Mesothelin binding molecule and application thereof | |
WO2023143547A1 (zh) | 抗cd28抗体及其应用 | |
EP4242232A1 (en) | Bispecific antibody and use thereof | |
WO2022028608A1 (zh) | 抗pd-l1抗体及其应用 | |
WO2022206677A1 (zh) | 抗vista抗体及其应用 | |
US20240026009A1 (en) | Antibodies to galectin-3 and methods of use thereof | |
CA3241487A1 (en) | Human epidermal growth factor receptor binding molecule and use thereof | |
CN114656567A (zh) | 抗icos抗体及其应用 | |
WO2024153163A1 (zh) | 抗cd93抗体及其应用 | |
WO2022247933A1 (zh) | 抗SIPRα抗体及其应用 | |
WO2023193794A1 (zh) | 抗vista抗体在联合用药中的应用 | |
WO2022022526A1 (zh) | 抗her2抗体及其应用 | |
CN116323658A (zh) | 靶向PD-1或PD-L1和TGF-β的双功能蛋白及其医药用途 | |
CA3239307A1 (en) | Caninized antibodies to canine interleukin-31 receptor alpha 1 | |
CN117510641A (zh) | 靶向cd112r和tigit的双特异性抗体及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |